Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Bornhäuser

Showing results (71-80 of 102) with videos related to

Pageof 11
Sort By:
Leukemia|August 21, 2013
Costimulation improves the killing capability of T cells redirected to tumor cells expressing low levels of CD33: description of a novel modular targeting systemC Arndt, A Feldmann, M von Bonin, et al.
Leukemia|December 8, 2010
Risk stratification using a new prognostic score for patients with secondary acute myeloid leukemia: results of the prospective AML96 trialF Stölzel, M Pfirrmann, W E Aulitzky, et al.
Leukemia|September 3, 2011
Azacitidine for treatment of imminent relapse in MDS or AML patients after allogeneic HSCT: results of the RELAZA trialU Platzbecker, M Wermke, J Radke, et al.
Bone Marrow Transplantation|September 30, 2008
Treatment of refractory acute GVHD with third-party MSC expanded in platelet lysate-containing mediumM von Bonin, F Stölzel, A Goedecke, et al.
Annals of Hematology|May 6, 2004
Imatinib mesylate selectively influences the cellular metabolism of cytarabine in BCR/ABL negative leukemia cell lines and normal CD34+ progenitor cellsM Bornhäuser, T Illmer, P Le Coutre, et al.
Bone Marrow Transplantation|January 12, 2016
Durable responses to ibrutinib in patients with relapsed CLL after allogeneic stem cell transplantationC S Link, R Teipel, F Heidenreich, et al.
Leukemia|March 10, 2001
Sequential monitoring of chimerism and detection of minimal residual disease after allogeneic blood stem cell transplantation (BSCT) using multiplex PCR amplification of short tandem repeat-markersC Thiede, M Bornhäuser, U Oelschlägel, et al.
Bone Marrow Transplantation|December 5, 2012
Comparison of conditioning regimens of various intensities for allogeneic hematopoietic SCT using HLA-identical sibling donors in AML and MDS with <10% BM blasts: a report from EBMTR Martino, L de Wreede, M Fiocco, et al.
Annals of Hematology|March 4, 2003
Reduced non-relapse mortality after reduced intensity conditioning in advanced chronic lymphocytic leukemiaJ Schetelig, C Thiede, M Bornhäuser, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 6, 2000
Clinical phase I dose escalation and pharmacokinetic study of high-dose chemotherapy with treosulfan and autologous peripheral blood stem cell transplantation in patients with advanced malignanciesM E Scheulen, R A Hilger, C Oberhoff, et al.
Pageof 11

Showing results (71-80 of 102) with videos related to

Sort By:
Pageof 11
Leukemia|August 21, 2013
Costimulation improves the killing capability of T cells redirected to tumor cells expressing low levels of CD33: description of a novel modular targeting systemC Arndt, A Feldmann, M von Bonin, et al.
Leukemia|December 8, 2010
Risk stratification using a new prognostic score for patients with secondary acute myeloid leukemia: results of the prospective AML96 trialF Stölzel, M Pfirrmann, W E Aulitzky, et al.
Leukemia|September 3, 2011
Azacitidine for treatment of imminent relapse in MDS or AML patients after allogeneic HSCT: results of the RELAZA trialU Platzbecker, M Wermke, J Radke, et al.
Bone Marrow Transplantation|September 30, 2008
Treatment of refractory acute GVHD with third-party MSC expanded in platelet lysate-containing mediumM von Bonin, F Stölzel, A Goedecke, et al.
Annals of Hematology|May 6, 2004
Imatinib mesylate selectively influences the cellular metabolism of cytarabine in BCR/ABL negative leukemia cell lines and normal CD34+ progenitor cellsM Bornhäuser, T Illmer, P Le Coutre, et al.
Bone Marrow Transplantation|January 12, 2016
Durable responses to ibrutinib in patients with relapsed CLL after allogeneic stem cell transplantationC S Link, R Teipel, F Heidenreich, et al.
Leukemia|March 10, 2001
Sequential monitoring of chimerism and detection of minimal residual disease after allogeneic blood stem cell transplantation (BSCT) using multiplex PCR amplification of short tandem repeat-markersC Thiede, M Bornhäuser, U Oelschlägel, et al.
Bone Marrow Transplantation|December 5, 2012
Comparison of conditioning regimens of various intensities for allogeneic hematopoietic SCT using HLA-identical sibling donors in AML and MDS with <10% BM blasts: a report from EBMTR Martino, L de Wreede, M Fiocco, et al.
Annals of Hematology|March 4, 2003
Reduced non-relapse mortality after reduced intensity conditioning in advanced chronic lymphocytic leukemiaJ Schetelig, C Thiede, M Bornhäuser, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 6, 2000
Clinical phase I dose escalation and pharmacokinetic study of high-dose chemotherapy with treosulfan and autologous peripheral blood stem cell transplantation in patients with advanced malignanciesM E Scheulen, R A Hilger, C Oberhoff, et al.
Pageof 11